about
Nimodipine in otolaryngology: from past evidence to clinical perspectivesThe role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain functionBiomarkers of cerebrovascular disease in dementia.Pharmacologic management of Alzheimer disease, Part II: Antioxidants, antihypertensives, and ergoloid derivatives.Calcium channel blockers in psychiatric disorders: a review of the literature.Learning and aging related changes in intrinsic neuronal excitabilitySusceptibility to Calcium Dysregulation during Brain Aging.Nimodipine for primary degenerative, mixed and vascular dementia.Lack of interaction between diazepam and nimodipine during chronic oral administration to healthy elderly subjects.Rationale and design of a double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of nimodipine in preventing cognitive impairment in ischemic cerebrovascular events (NICE)Dissecting the age-related decline on spatial learning and memory tasks in rodent models: N-methyl-D-aspartate receptors and voltage-dependent Ca2+ channels in senescent synaptic plasticityPhysiology and pathology of calcium signaling in the brain.Sex-dependent modulation of age-related cognitive decline by the L-type calcium channel gene Cacna1c (Cav 1.2)Surface L-type Ca2+ channel expression levels are increased in aged hippocampus.A Review of Pharmacological Treatments for Depression in Alzheimer's Disease.Cross-disorder risk gene CACNA1C differentially modulates susceptibility to psychiatric disorders during development and adulthood.Calcium homeostasis in aging neurons.Efficacy of acetylcholinesterase inhibitors versus nootropics in Alzheimer's disease: a retrospective, longitudinal study.Development and pharmacokinetics of nimodipine-loaded liposomes.
P2860
Q26798286-0450DC99-22F5-41BF-8812-9E994DE32A58Q28243321-EBD3AF53-761C-44E0-BC39-2C7EF24B6060Q31153979-FDB53403-2000-47F8-B2DE-82E5F4ED3889Q33543113-D11A9AEC-A35A-4082-A7CE-3D0D54038789Q33740406-D1BBEF52-BA30-4036-B501-A5B1F8878E7CQ33868397-479587B8-4B59-4EF6-8F8C-3B4DE1B163A0Q33868432-DF18D889-418B-4293-BE94-E7D9F2C69B4CQ33908544-74491D9D-9347-40ED-97B8-043AF0F7BD2CQ34346475-52432A82-7F92-4F08-A7F3-DC3E258223AFQ34403971-C59E654E-F264-4785-BD1B-355A5DB8610CQ35840136-8AFE17AA-1EBC-41C3-9040-8780090758ECQ35886492-16790B89-CAE0-47DA-B66C-0190A2E3E535Q36190437-19B6DBE0-A151-4CCD-A1AD-3E040925BCAAQ37625596-7BE2112F-790B-4BE6-AD7E-8306A0136EE9Q38592128-F7B32722-2980-4699-A9D4-F5622F041C5BQ39309436-1AAA6794-0CFF-486E-9FE5-5158888345D5Q42534539-C2B0DBB2-60F9-4257-B4A9-254340E8923FQ43558449-26715BAC-E124-47BF-A362-677A29539EF8Q48432095-9001D902-61D4-4FA1-8596-DE3E3EA0B652
P2860
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Nimodipine in the treatment of old age dementias.
@en
Nimodipine in the treatment of old age dementias.
@nl
type
label
Nimodipine in the treatment of old age dementias.
@en
Nimodipine in the treatment of old age dementias.
@nl
prefLabel
Nimodipine in the treatment of old age dementias.
@en
Nimodipine in the treatment of old age dementias.
@nl
P2093
P1476
Nimodipine in the treatment of old age dementias
@en
P2093
M Sterlicchio
N A Tomasi
N Caglieris
O Azzarelli
V Marigliano
P304
P356
10.1016/0278-5846(90)90005-2
P577
1990-01-01T00:00:00Z